Prestige Consumer Healthcare (PBH) Prepaid Assets (2011 - 2025)
Prestige Consumer Healthcare's (PBH) quarterly Prepaid Assets came in at $17.0 million in Q4 2025, up 126.73% year-on-year from $7.5 million in Q4 2024, and down 16.27% quarter-over-quarter from $20.3 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Prepaid Assets (2011 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Prepaid Assets history runs 15 years deep, the most recent figure standing at $17.0 million for Q4 2025.
- On a quarterly basis, Prepaid Assets rose 126.73% year-over-year to $17.0 million in Q4 2025; TTM through Dec 2025 was $17.0 million, a 126.73% increase from a year earlier, with the FY2025 full-year figure at $8.4 million, down 35.47% from the prior year.
- Prepaid Assets fell to $17.0 million in Q4 2025 per PBH's latest filing, from $20.3 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $20.3 million in Q3 2025 and bottomed at $4.1 million in Q1 2023.
- The 5-year median for Prepaid Assets is $8.7 million (2021), against an average of $10.2 million.
- Across the five-year window, Prepaid Assets sank 49.78% in 2022 and jumped 217.76% in 2024, its largest moves.
- Year by year, Prepaid Assets stood at $13.7 million in 2021, then sank by 49.78% to $6.9 million in 2022, then advanced by 5.23% to $7.2 million in 2023, then increased by 3.51% to $7.5 million in 2024, then jumped by 126.73% to $17.0 million in 2025.
- Per Business Quant, the three latest PBH Prepaid Assets figures stand at $17.0 million (Q4 2025), $20.3 million (Q3 2025), and $19.5 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Prestige Consumer Healthcare | 2.34 Bn | 2.28 Bn | 157.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17.01 Mn |
| Sep 30, 2025 | 20.31 Mn |
| Jun 30, 2025 | 19.49 Mn |
| Mar 31, 2025 | 8.44 Mn |
| Dec 31, 2024 | 7.50 Mn |
| Sep 30, 2024 | 9.40 Mn |
| Jun 30, 2024 | 10.75 Mn |
| Mar 31, 2024 | 13.08 Mn |
| Dec 31, 2023 | 7.25 Mn |
| Sep 30, 2023 | 8.39 Mn |
| Jun 30, 2023 | 9.38 Mn |
| Mar 31, 2023 | 4.12 Mn |
| Dec 31, 2022 | 6.89 Mn |
| Sep 30, 2022 | 7.71 Mn |
| Jun 30, 2022 | 9.53 Mn |
| Mar 31, 2022 | 6.41 Mn |
| Dec 31, 2021 | 13.71 Mn |
| Sep 30, 2021 | 7.52 Mn |
| Jun 30, 2021 | 9.01 Mn |
| Mar 31, 2021 | 7.90 Mn |